BIQUETAN 150 mg prolonged-release tablet

BIQUETAN 150 mg prolonged-release tablet

Marketed by: STADA Arzneimittel AG
Active ingredient: Quetiapine fumarate
Other information: prolonged-release tablet - 150 mg

Available in: Finland
Language: English
Source: Fimea

BIQUETAN 50 mg prolonged-release tablet

BIQUETAN 50 mg prolonged-release tablet

Marketed by: STADA Arzneimittel AG
Active ingredient: Quetiapine fumarate
Other information: prolonged-release tablet - 50 mg

Available in: Finland
Language: English
Source: Fimea

BIOCLAVID 80 / 11.4 mg/ml powder for oral suspension

BIOCLAVID 80 / 11.4 mg/ml powder for oral suspension

Marketed by: Sandoz GmbH
Active ingredient: Kalii Clavulan, Amoxicillin Sandoz
Other information: powder for oral suspension - 80 / 11.4 mg/ml

Available in: Finland
Language: English
Source: Fimea

BIOCLAVID 875 mg / 125 mg film-coated tablet

BIOCLAVID 875 mg / 125 mg film-coated tablet

Marketed by: Sandoz GmbH
Active ingredient: Amoxicillin Sandoz, Kalii Clavulan
Other information: film-coated tablet - 875 mg / 125 mg

Available in: Finland
Language: English
Source: Fimea

BIOCLAVID 500 mg / 125 mg film-coated tablet

BIOCLAVID 500 mg / 125 mg film-coated tablet

Marketed by: Sandoz GmbH
Active ingredient: Kalii Clavulan, Amoxicillin Sandoz
Other information: film-coated tablet - 500 mg / 125 mg

Available in: Finland
Language: English
Source: Fimea

BIMATOPROST/TIMOLOL STADA 0.3 mg/ml + 5 mg/ml eye drops, solution

BIMATOPROST/TIMOLOL STADA 0.3 mg/ml + 5 mg/ml eye drops, solution

Marketed by: STADA Arzneimittel AG
Active ingredient: Timololi maleas,Bimatoprostum
Other information: eye drops, solution - 0.3 mg/ml + 5 mg/ml

Available in: Finland
Language: English
Source: Fimea

BIMATOPROST/TIMOLOL MYLAN 0.3 mg/ml + 5 mg/ml eye drops, solution

BIMATOPROST/TIMOLOL MYLAN 0.3 mg/ml + 5 mg/ml eye drops, solution

Marketed by: Mylan AB
Active ingredient: Bimatoprostum,Timololi maleas
Other information: eye drops, solution - 0.3 mg/ml + 5 mg/ml

Available in: Finland
Language: English
Source: Fimea

BIMATOPROST STADA 0.3 mg/ml eye drops, solution

BIMATOPROST STADA 0.3 mg/ml eye drops, solution

Marketed by: Stada Arzneimittel AG
Active ingredient: Bimatoprost
Other information: eye drops, solution - 0.3 mg/ml

Available in: Finland
Language: English
Source: Fimea

BIMATOPROST SANDOZ 0.3 mg/ml eye drops, solution

BIMATOPROST SANDOZ 0.3 mg/ml eye drops, solution

Marketed by: Sandoz A/S
Active ingredient: Bimatoprost
Other information: eye drops, solution - 0.3 mg/ml

Available in: Finland
Language: English
Source: Fimea

BEZALIP 400 mg prolonged-release tablet

BEZALIP 400 mg prolonged-release tablet

Marketed by: Paranova Oy
Active ingredient: Bezafibratum
Other information: prolonged-release tablet - 400 mg

Available in: Finland
Language: English
Source: Fimea

BEZALIP 400 mg prolonged-release tablet

BEZALIP 400 mg prolonged-release tablet

Marketed by: Actavis Group PTC ehf
Active ingredient: Bezafibratum
Other information: prolonged-release tablet - 400 mg

Available in: Finland
Language: English
Source: Fimea

BEVACOMB 10 mg / 160 mg film-coated tablet

BEVACOMB 10 mg / 160 mg film-coated tablet

Marketed by: Actavis Group PTC ehf
Active ingredient: Valsartanum,Amlodipini besilas
Other information: film-coated tablet - 10 mg / 160 mg

Available in: Finland
Language: English
Source: Fimea

BEVACOMB 5 mg / 160 mg film-coated tablet

BEVACOMB 5 mg / 160 mg film-coated tablet

Marketed by: Actavis Group PTC ehf
Active ingredient: Valsartanum,Amlodipini besilas
Other information: film-coated tablet - 5 mg / 160 mg

Available in: Finland
Language: English
Source: Fimea

BEVACOMB 5 mg / 80 mg film-coated tablet

BEVACOMB 5 mg / 80 mg film-coated tablet

Marketed by: Actavis Group PTC ehf
Active ingredient: Valsartanum,Amlodipini besilas
Other information: film-coated tablet - 5 mg / 80 mg

Available in: Finland
Language: English
Source: Fimea

BETOPTIC S 2.5 mg/ml eye drops, suspension in single-dose container

BETOPTIC S 2.5 mg/ml eye drops, suspension in single-dose container

Marketed by: Novartis Finland Oy
Active ingredient: Betaxololi hydrochloridum
Other information: eye drops, suspension in single-dose container - 2.5 mg/ml

Available in: Finland
Language: English
Source: Fimea

BETOPTIC S 2.5 mg/ml eye drops, suspension

BETOPTIC S 2.5 mg/ml eye drops, suspension

Marketed by: Novartis Finland Oy
Active ingredient: Betaxololi hydrochloridum
Other information: eye drops, suspension - 2.5 mg/ml

Available in: Finland
Language: English
Source: Fimea

BETOPTIC 5 mg/ml eye drops, solution

BETOPTIC 5 mg/ml eye drops, solution

Marketed by: Novartis Finland Oy
Active ingredient: Betaxololi hydrochloridum
Other information: eye drops, solution - 5 mg/ml

Available in: Finland
Language: English
Source: Fimea

BETASERC 24 mg tablet

BETASERC 24 mg tablet

Marketed by: Paranova Oy
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 24 mg

Available in: Finland
Language: English
Source: Fimea

BETASERC 24 mg orodispersible tablet

BETASERC 24 mg orodispersible tablet

Marketed by: Mylan IRE Healthcare Limited
Active ingredient: Betahistini dihydrochloridum
Other information: orodispersible tablet - 24 mg

Available in: Finland
Language: English
Source: Fimea

BETASERC 24 mg tablet

BETASERC 24 mg tablet

Marketed by: Mylan Healthcare B.V.
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 24 mg

Available in: Finland
Language: English
Source: Fimea

BETASERC 16 mg tablet

BETASERC 16 mg tablet

Marketed by: Mylan Healthcare B.V.
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 16 mg

Available in: Finland
Language: English
Source: Fimea

BETASERC 8 mg tablet

BETASERC 8 mg tablet

Marketed by: Mylan Healthcare B.V.
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 8 mg

Available in: Finland
Language: English
Source: Fimea

BETAKLAV 875 mg / 125 mg film-coated tablet

BETAKLAV 875 mg / 125 mg film-coated tablet

Marketed by: KRKA Sverige AB
Active ingredient: Amoxicillin Sandoz, Kalii Clavulan
Other information: film-coated tablet - 875 mg / 125 mg

Available in: Finland
Language: English
Source: Fimea

BETAKLAV 500 mg / 125 mg film-coated tablet

BETAKLAV 500 mg / 125 mg film-coated tablet

Marketed by: KRKA Sverige AB
Active ingredient: Kalii Clavulan, Amoxicillin Sandoz
Other information: film-coated tablet - 500 mg / 125 mg

Available in: Finland
Language: English
Source: Fimea

BETAHISTIN RATIOPHARM 16 mg tablet

BETAHISTIN RATIOPHARM 16 mg tablet

Marketed by: ratiopharm Oy
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 16 mg

Available in: Finland
Language: English
Source: Fimea

BETAHISTIN RATIOPHARM 8 mg tablet

BETAHISTIN RATIOPHARM 8 mg tablet

Marketed by: ratiopharm Oy
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 8 mg

Available in: Finland
Language: English
Source: Fimea

BETAHISTIN ORION 24 mg tablet

BETAHISTIN ORION 24 mg tablet

Marketed by: Orion Corporation
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 24 mg

Available in: Finland
Language: English
Source: Fimea

BETAHISTIN ORION 16 mg tablet

BETAHISTIN ORION 16 mg tablet

Marketed by: Orion Corporation
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 16 mg

Available in: Finland
Language: English
Source: Fimea

BETAHISTIN ORION 8 mg tablet

BETAHISTIN ORION 8 mg tablet

Marketed by: Orion Corporation
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 8 mg

Available in: Finland
Language: English
Source: Fimea

BETAHISTIN ORIFARM GENERICS 24 mg tablet

BETAHISTIN ORIFARM GENERICS 24 mg tablet

Marketed by: Orifarm Generics A/S
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 24 mg

Available in: Finland
Language: English
Source: Fimea

BETAHISTIN ORIFARM GENERICS 16 mg tablet

BETAHISTIN ORIFARM GENERICS 16 mg tablet

Marketed by: Orifarm Generics A/S
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 16 mg

Available in: Finland
Language: English
Source: Fimea

BETAHISTIN ORIFARM GENERICS 8 mg tablet

BETAHISTIN ORIFARM GENERICS 8 mg tablet

Marketed by: Orifarm Generics A/S
Active ingredient: Betahistini dihydrochloridum
Other information: tablet - 8 mg

Available in: Finland
Language: English
Source: Fimea